Beam stock forecast.

In 2021, Vertex acquired the rights to 60% of the profits from sales of Crispr Therapeutics gene-editing therapy CTX001, now called exa-cel, for up to $1.1 billion, pending regulatory approval ...Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Iridium Communications Inc have a median target of 65.00, with a high estimate of 75.00 and a low estimate of 53.00. The ...Get Beam Therapeutics Inc (BEAM.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years.

See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.NEW YORK, February 15, 2023--Beam Suntory, a world leader in premium spirits, today announced 2022 full year results, with net sales up 10.5% year on year, representing 24% growth versus the pre ...Aug 13, 2023 · The Vanguard Group, Inc. is the second largest shareholder owning 8.3% of common stock, and Arch Venture Partners, L.P. holds about 7.1% of the company stock. Furthermore, CEO John Evans is the ...

Apr 20, 2023 · Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ... The first Wood-backed stock we’ll look at is Beam Therapeutics, ... Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast)

(See BEAM stock forecast on TipRanks) iHeartMedia (IHRT) Let’s switch stations now and tune into something entirely different. iHeartMedia is one of the U.S.’s most prominent audio companies ...Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.$-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend …Jun 13, 2022 - Beam Therapeutics stock forecast & analyst price target predictions based on 9 analysts offering 12-months price targets for BEAM in the last 3 months. Pinterest. Today. Watch. Shop. Explore. When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with ...Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ...

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

The Beam Global stock price fell by -1.95% on the last day (Wednesday, 29th Nov 2023) from $6.14 to $6.02. During the last trading day the stock fluctuated 9.27% from a day low at $6.01 to a day high of $6.57. The price has fallen in 7 of the last 10 days and is down by -17.53% for this period. Volume fell on the last day along with the stock ...

Wall Street Analysts Believe Beam Therapeutics Inc. (BEAM) Could Rally 81.29%: Here's is How to Trade The mean of analysts' price targets for Beam Therapeutics Inc. (BEAM) …BEEM Stock 12 Months Forecast. $24.00. (228.09% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Beam Global in the last 3 months. The average price target is $24.00 with a high forecast of $40.00 and a low forecast of $12.00. The average price target represents a 228.09% change from the last price of $7.32.Find real-time MELI - MercadoLibre Inc stock quotes, company profile, news and forecasts from CNN Business.Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, ... EPS forecast (this quarter)-$0.07: Annual revenue (last year) $477.7M: Annual profit (last year)3 Wall Street research analysts have issued 12-month price targets for Beam Global's shares. Their BEEM share price targets range from $25.00 to $25.00. On average, they anticipate the company's stock price to reach $25.00 in the next year. This suggests a possible upside of 315.3% from the stock's current price.According to 4 Wall Street analyst s that have issued a 1 year BEAM price target, the average BEAM price target is $42.50, with the highest BEAM stock price forecast at …

Ginkgo Bioworks Holdings Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for DNA stock stock is $1.88, which predicts an increase of 45.74%. The lowest target is $1.25 and the highest is $2.50.Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -8.44M. -19.71%. Get the latest Beam Global (BEEM) real-time quote ...SMM Review and Outlook of Copper and Aluminum Market in 2023-2024. Nov 29, 2023 17:35. UBS Base Metals Outlook 2024: Copper Will See A Supply Deficit, Aluminum Prices Will Be Higher Later In 2024, Lead And Zinc Will Be In Small Surplus ... LME, SHFE and COMEX copper stocks all hit multi-month low, with SHFE copper …Find the latest Beam Global (BEEM) stock quote, history, news and other vital information to help you with your stock trading and investing.(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage diagnostics company that provides care for transplant patients, from finding the right match to follow-on surveillance post-transplant.Infibeam Avenue Share Price: Find the latest news on Infibeam Avenue Stock Price. Get all the information on Infibeam Avenue with historic price charts for ...

Lumber increased 29.16 USD/1000 board feet or 5.87% since the beginning of 2023, according to trading on a contract for difference (CFD) that tracks the benchmark market for this commodity. Lumber - values, historical data, forecasts and news - updated on December of 2023.Stock Splits: Mergers & Acquisitions: Business Services/Equipment M&A Construction M&A General Contractors & Builders M&A Consumer Goods M&A Sporting Goods & Activities M&A Office Supplies M&A Food & Beverage M&A Beverages & Wineries M&A Cigarettes & Tobacco M&A Marijuana Stocks M&A Apparel Stores M&A Department Stores M&A …

Based on those assumptions, my modeling says Aeva could do about $10 in earnings per share by 2030. A simple 20X multiple on that implies a long-term potential price target here of $200. The AEVA ...Dec 1, 2023 · John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ... $-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend …Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing ...Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Beam Global analyst ratings, historical stock prices, earnings estimates & actuals. BEEM updated stock price target summary.January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...According to 3 stock analysts, the average 12-month stock price forecast for Beam Global stock is $26.67, which predicts an increase of 343.02%. The lowest target is $25 and the highest is $30. On average, analysts rate Beam Global stock as a strong buy.As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing ...

Pricing Details. The global bridge construction market size was valued at $857.7 billion in 2020, and is projected to reach $1,416.9 billion by 2030, registering a CAGR of 5.0% from 2021 to 2030. A bridge is a super-structure that spans horizontally between supports. The major function of a bridge is to carry vertical loads.

Get The Latest CRWD Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content S&P 500 4,594.63 (+0.59%)

Here are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ...Nov 29, 2023 · According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest target is $32 and the highest is $105. On average, analysts rate BEAM stock stock as a buy. Nov 15, 2023 · Earnings vs Market: BEEM is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: BEEM is expected to become profitable in the next 3 years. Revenue vs Market: BEEM's revenue (24.5% per year) is forecast to grow faster than the US market (7.7% per year). Jul 15, 2023 · Here are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ... Find real-time HAL - Halliburton Co stock quotes, company profile, news and forecasts from CNN Business.Find real-time ADPT - Adaptive Biotechnologies Corp stock quotes, company profile, news and forecasts from CNN Business.Get The Latest CRWD Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content S&P 500 4,594.63 (+0.59%)According to 3 analysts, the average rating for BEEM stock is "Strong Buy." The 12-month stock price forecast is $26.67, which is an increase of 343.02% from the latest price.SmartAssetPaid Partner. Find real-time FSR - Fisker Inc stock quotes, company profile, news and forecasts from CNN Business.Based on 5 Buys and 4 Holds, the analyst consensus rates the stock a Moderate Buy. Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast) CareDx, Inc (CDNA) The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition.Jun 12, 2022 · Beam Therapeutics Let’s start off in the high-risk, high-reward biotech sector. ... (See IHRT stock forecast on TipRanks) To find good ideas for stocks trading at attractive valuations, visit ... October 30, 2023 at 7:00 AM · 5 min read. Wall Street expects a year-over-year increase in earnings on lower revenues when Beam Therapeutics Inc. (BEAM) reports results for the quarter ended ...

BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I …14 Days Historical Data BEAM : Beam Therapeutics stock forecast by Wall Street Analysts The average Beam Therapeutics stock forecast from last 6 month is $47.0, and this …Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Drug-developer Vaxart ( VXRT -1.13%) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of ...Instagram:https://instagram. interactive brokers vs td ameritradespnebotox for teeth grinding covered by insuranceffo for reits (NASDAQ: SGMO) Sangamo Therapeutics's forecast annual revenue growth rate of -28.5% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.51%. broadcom vmwarehow can i buy preferred stock Nov 29, 2023 · According to 3 analysts, the average rating for BEEM stock is "Strong Buy." The 12-month stock price forecast is $26.67, which is an increase of 343.02% from the latest price. cryptocurrency applications Beam Global Stock Forecast and Price Target. In recent months, notable analysts have provided yearlong price targets for Beam Global, with the average target coming in at $18.00. If it were to be achieved, this would result in a potential upside of approximately 222 percent from the most recent closing price in November, 2023.Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Iridium Communications Inc have a median target of 65.00, with a high estimate of 75.00 and a low estimate of 53.00. The ...Beam Therapeutics is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. ... We provide commentary based on historical data and analyst forecasts ...